Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
The Manila Times on MSN
What's new in YouTube's teen safety and family features
YOU can see it in any household with a teen. The phone comes out before exams. YouTube opens for vlogs and podcasts. Sports ...
The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to ...
Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.
Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.
At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...
A short-term oat-based diet appears to be surprisingly effective at reducing the cholesterol level. This is indicated by a ...
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not ...
A cow named Veronika stunned scientists after being filmed using a tool, forcing researchers to rethink what intelligence ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results